Abstract

938P Nivolumab (nivo) in recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN): real-world effectiveness, quality of life (QoL) of patients and their caregivers in France (ProNiHN study)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Breakthrough targeted therapeutic approaches to squamous cell carcinoma of the head and neck.
Georgios D Lianos ... Alessandro Mangano
Future oncology (London, England) | VOL. 11
Georgios D Lianos, et. al.Georgios D Lianos ... Alessandro Mangano
01 Jan 2015
Effectiveness of PD-L1 inhibitors in metastatic or recurrent squamous cell carcinoma of head and neck: An observational, indirect comparison.
Jeroen Van Dessel ... Michel Bila
Journal of Clinical Oncology | VOL. 38
Jeroen Van Dessel, et. al.Jeroen Van Dessel ... Michel Bila
20 May 2020
Recurrent squamous cell carcinoma of head and neck: results of treatment in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine in 2012–2016
M M Sarycheva ... A V Vazhenin
Head and Neck Tumors (HNT) | VOL. 10
M M Sarycheva, et. al.M M Sarycheva ... A V Vazhenin
11 Apr 2020
Combined use of cetuximab and chemotherapy in recurrent or metastatic squamous cell carcinoma of head and neck
Journal of International Oncology | VOL. 37
08 Dec 2010
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers